Genetic secrets of long-term glioblastoma survivors

per Jovčevska, Ivana
Publicat a Bosn J Basic Med Sci (2019)

Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma

per Jovčevska, Ivana
Publicat a Front Oncol (2020)

The Therapeutic Potential of Nanobodies

per Jovčevska, Ivana, Muyldermans, Serge
Publicat a BioDrugs (2019)

Glioma and glioblastoma - how much do we (not) know?

per JOVČEVSKA, IVANA, KOČEVAR, NINA, KOMEL, RADOVAN
Publicat 2013

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy

per Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Publicat a Materials (Basel) (2019)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

per Šamec, Neja, Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Publicat a Molecules (2020)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

per Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana
Publicat a Cancers (Basel) (2020)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas

per Jovčevska, Ivana, Zottel, Alja, Šamec, Neja, Mlakar, Jernej, Sorokin, Maxim, Nikitin, Daniil, Buzdin, Anton A., Komel, Radovan
Publicat a Cancers (Basel) (2019)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

per Zottel, Alja, Jovčevska, Ivana, Šamec, Neja, Mlakar, Jernej, Šribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, Radovan
Publicat a Ther Adv Med Oncol (2020)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates

per Vidak, Marko, Jovcevska, Ivana, Samec, Neja, Zottel, Alja, Liovic, Mirjana, Rozman, Damjana, Dzeroski, Saso, Juvan, Peter, Komel, Radovan
Publicat a Int J Mol Sci (2018)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

per Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Publicat a Oncotarget (2018)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive...

per Jovčevska, Ivana, Zupanec, Neja, Urlep, Žiga, Vranič, Andrej, Matos, Boštjan, Stokin, Clara Limbaeck, Muyldermans, Serge, Myers, Michael P., Buzdin, Anton A., Petrov, Ivan, Komel, Radovan
Publicat a Oncotarget (2017)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

per Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Publicat a Cancers (Basel) (2021)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles

per Zottel, Alja, Šamec, Neja, Kump, Ana, Dall’Olio, Lucija Raspor, Pužar Dominkuš, Pia, Romih, Rok, Hudoklin, Samo, Mlakar, Jernej, Nikitin, Daniil, Sorokin, Maxim, Buzdin, Anton, Jovčevska, Ivana, Komel, Radovan
Publicat a Int J Mol Sci (2020)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers

per Jovčevska, Ivana, Zupanec, Neja, Kočevar, Nina, Cesselli, Daniela, Podergajs, Neža, Stokin, Clara Limbaeck, Myers, Michael P., Muyldermans, Serge, Ghassabeh, Gholamreza Hassanzadeh, Motaln, Helena, Ruaro, Maria Elisabetta, Bourkoula, Evgenia, Turnšek, Tamara Lah, Komel, Radovan
Publicat a PLoS One (2014)

Advances in Molecular Genetics of Brain Tumors

Publicat 2023

Advances in Molecular Genetics of Brain Tumors

Publicat 2023